ETF Managers Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $213K | Buy |
+8,890
| New | +$213K | 0.01% | 577 |
|
|
2022
Q4 | – | Sell |
-7,843
| Closed | -$116K | – | 529 |
|
|
2022
Q3 | $116K | Sell |
7,843
-504
| -6% | -$7.45K | ﹤0.01% | 643 |
|
|
2022
Q2 | $129K | Buy |
8,347
+347
| +4% | +$5.36K | ﹤0.01% | 673 |
|
|
2022
Q1 | $220K | Buy |
8,000
+31
| +0.4% | +$853 | ﹤0.01% | 597 |
|
|
2021
Q4 | $310K | Sell |
7,969
-1,150
| -13% | -$44.7K | 0.01% | 591 |
|
|
2021
Q3 | $426K | Buy |
9,119
+1,356
| +17% | +$63.3K | 0.01% | 562 |
|
|
2021
Q2 | $268K | Sell |
7,763
-10,058
| -56% | -$347K | ﹤0.01% | 592 |
|
|
2021
Q1 | $691K | Buy |
17,821
+5,908
| +50% | +$229K | 0.01% | 334 |
|
|
2020
Q4 | $556K | Sell |
11,913
-1,755
| -13% | -$81.9K | 0.01% | 322 |
|
|
2020
Q3 | $584K | Buy |
13,668
+7,008
| +105% | +$299K | 0.02% | 278 |
|
|
2020
Q2 | $313K | Buy |
+6,660
| New | +$313K | 0.01% | 392 |
|